We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current OFSA3 market cap is 1.23B. The company's latest EPS is BRL 2.4899 and P/E is 9.13.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Revenue | 305.94M | 199.2M | 241.31M | 237.65M | 452.87M |
| Operating Income | 32.78M | 20.85M | 26.26M | 62.49M | 76.79M |
| Net Income | 19.71M | 12.85M | 16.9M | 41.61M | 62.98M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Revenue | 798M | 991.35M | 1.14B | 1.03B | 1.13B |
| Operating Income | 104.81M | 141.11M | 177.32M | 80.7M | 186.39M |
| Net Income | 89.72M | 113.96M | 130.66M | -49.98M | 134.33M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Assets | 1.28B | 1.29B | 1.31B | 1.31B | 1.38B |
| Total Liabilities | 589.61M | 589.16M | 617.2M | 579.84M | 628.29M |
| Total Equity | 689.4M | 702.81M | 689.48M | 728.99M | 756.42M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Assets | 1.1B | 1.19B | 1.35B | 1.28B | 1.38B |
| Total Liabilities | 543.13M | 551.17M | 610.54M | 589.61M | 628.29M |
| Total Equity | 560.81M | 641.47M | 735.97M | 689.4M | 756.42M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Operating | 190.3M | 67.48M | 99.97M | 77.3M | 73.94M |
| Investing | -37.14M | -10.39M | -17.61M | -26.18M | -42.88M |
| Financing | -14.36M | -12.03M | -43.83M | -96.55M | -102.17M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Operating | 111.94M | 46.5M | 89.59M | 190.3M | 73.94M |
| Investing | -23.53M | -60.41M | -78.15M | -37.14M | -42.88M |
| Financing | 91.52M | -50.62M | -7.95M | -14.36M | -102.17M |
| Market Cap | 1.23B |
| Price to Earnings Ratio | 9.13 |
| Price to Sales Ratio | 1.08 |
| Price to Cash Ratio | 5.24 |
| Price to Book Ratio | 1.62 |
| Dividend Yield | - |
| Shares Outstanding | 53.95M |
| Average Volume (1 week) | 3.36k |
| Average Volume (1 Month) | 3.17k |
| 52 Week Change | 3.32% |
| 52 Week High | 23.40 |
| 52 Week Low | 16.01 |
| Spread (Intraday) | 1.82 (7.92%) |
| Company Name | Ourofino S.A |
| Address |
rodovia anhanguera sp 330, km 298 cravinhos, sao paulo |
| Website | https://www.ourofinosaudeanimal.com |
| Industry | veterinary svcs-animal specs (0742) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
